521 related articles for article (PubMed ID: 19460975)
1. Biotechnology. Lawsuit challenges legal basis for patenting human genes.
Marshall E
Science; 2009 May; 324(5930):1000-1. PubMed ID: 19460975
[No Abstract] [Full Text] [Related]
2. ACLU lawsuit questions the patenting of breast cancer genes.
Printz C
Cancer; 2009 Nov; 115(21):4887-8. PubMed ID: 19842208
[No Abstract] [Full Text] [Related]
3. Ruling on BRCA gene patents could have limited impact.
Goozner M
J Natl Cancer Inst; 2010 Jun; 102(11):754-7. PubMed ID: 20498427
[No Abstract] [Full Text] [Related]
4. [Federal judge and government of the United States against gene patenting].
Cassier M; Stoppa-Lyonnet D
Med Sci (Paris); 2011; 27(6-7):662-6. PubMed ID: 21718652
[No Abstract] [Full Text] [Related]
5. Diagnostics firms face new patent claim worries.
Allison M
Nat Biotechnol; 2009 Jul; 27(7):586-7. PubMed ID: 19587651
[No Abstract] [Full Text] [Related]
6. Intellectual property. Supreme Court rules out patents on 'natural' genes.
Marshall E
Science; 2013 Jun; 340(6139):1387-8. PubMed ID: 23788772
[No Abstract] [Full Text] [Related]
7. Patents. U.S. appeals court hears gene patent arguments.
Marshall E
Science; 2012 Jul; 337(6092):277-8. PubMed ID: 22822118
[No Abstract] [Full Text] [Related]
8. Genes can't be patented, rules Supreme Court.
McCarthy M
BMJ; 2013 Jun; 346():f3907. PubMed ID: 23771229
[No Abstract] [Full Text] [Related]
9. Biotechnology patents: strategies for meeting economic and ethical concerns.
Gold ER
Nat Genet; 2002 Apr; 30(4):359. PubMed ID: 11925560
[No Abstract] [Full Text] [Related]
10. Prometheus bound, but myriad loose ends: amid new legal battles over BRCA tests, technology may resolve what the courts have not.
Nelson B
Cancer Cytopathol; 2013 Oct; 121(10):535-6. PubMed ID: 24130100
[No Abstract] [Full Text] [Related]
11. European opposition to exclusive control over predictive breast cancer testing and the inherent implications for U.S. patent law and public policy: a case study of the Myriad Genetics' BRCA patent controversy.
Paradise J
Food Drug Law J; 2004; 59(1):133-54. PubMed ID: 15190928
[No Abstract] [Full Text] [Related]
12. Europe's patent rebellion.
Wadman M
Fortune; 2001 Oct; 144(6):44. PubMed ID: 11586878
[No Abstract] [Full Text] [Related]
13. Department of Justice opposes patents on isolated genes.
Levenson D
Am J Med Genet A; 2011 Feb; 155A(2):vii-viii. PubMed ID: 21271638
[No Abstract] [Full Text] [Related]
14. Patentable subject matter, TRIPS and the European Biotechnology Directive: Australia and patenting human genes.
Palombi L
Univ N S W Law J; 2003; 26(3):782-92. PubMed ID: 16617532
[No Abstract] [Full Text] [Related]
15. Patents. Cancer gene patents ruled invalid.
Marshall E
Science; 2010 Apr; 328(5975):153. PubMed ID: 20378781
[No Abstract] [Full Text] [Related]
16. The gene patenting controversy: a convergence of law, economic interests, and ethics.
Kevles DJ; Berkowitz A
Brooklyn Law Rev; 2001; 67(1):233-48. PubMed ID: 12645549
[No Abstract] [Full Text] [Related]
17. Patenting human life and the rebirth of the Thirteenth Amendment.
McDonald ES
Notre Dame Law Rev; 2003 May; 78(4):1359-87. PubMed ID: 15237536
[No Abstract] [Full Text] [Related]
18. History of a gene patent: tracing the development and application of commercial BRCA testing.
Williams-Jones B
Health Law J; 2002; 10():123-46. PubMed ID: 14748275
[No Abstract] [Full Text] [Related]
19. OTA panel opens inquiry into patenting of genes.
Macilwain C
Nature; 1993 Apr; 362(6419):386. PubMed ID: 8464461
[No Abstract] [Full Text] [Related]
20. Genetics. Trends in human gene patent litigation.
Holman CM
Science; 2008 Oct; 322(5899):198-9. PubMed ID: 18845733
[No Abstract] [Full Text] [Related]
[Next] [New Search]
